4.7 Article

Inflammation-induced hypoparathyroidism triggered by combination immune checkpoint blockade for melanoma

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Immune Checkpoint Inhibitor-Induced Hypoparathyroidism Associated With Calcium-Sensing Receptor-Activating Autoantibodies

Paramarajan Piranavan et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)

Review Medicine, General & Internal

Immune-Related Adverse Events Associated with Immune Checkpoint Blockade

Michael A. Postow et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Oncology

Fundamental Mechanisms of Immune Checkpoint Blockade Therapy

Spencer C. Wei et al.

CANCER DISCOVERY (2018)

Article Biochemistry & Molecular Biology

Is autoimmunity the Achilles' heel of cancer immunotherapy?

Carl H. June et al.

NATURE MEDICINE (2017)

Review Endocrinology & Metabolism

Cancer immunotherapy - immune checkpoint blockade and associated endocrinopathies

David J. Byun et al.

NATURE REVIEWS ENDOCRINOLOGY (2017)

Article Oncology

Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade

Heinz Laubli et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)

Article Emergency Medicine

Acute symptomatic hypocalcemia from immune checkpoint therapy-induced hypoparathyroidism

Myint Aung Win et al.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2017)

Article Medicine, General & Internal

Fulminant Myocarditis with Combination Immune Checkpoint Blockade

Douglas B. dbj Johnson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Oncology

Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1

Jarushka Naidoo et al.

CANCER IMMUNOLOGY RESEARCH (2016)

Article Endocrinology & Metabolism

Activating Autoantibodies against the Calcium-Sensing Receptor Detected in Two Patients with Autoimmune Polyendocrine Syndrome Type 1

E. Helen Kemp et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)